BIOQUAL Presents Financial Results for Fiscal Year 2013
29 10월 2013 - 10:46PM
Business Wire
BIOQUAL, Inc. (Pinksheets: BIOQ):
2013
2012
Revenue $ 20,204,308 $ 22,667,149 (Loss) Income Before
Income Tax $ (107,016 ) $ 362,199 Net (Loss) Income $
(87,244 ) $ 213,971
Basic (Loss) Earnings per Share of Common
Stock
$
(.10
)
$
.24
Diluted (Loss) Earnings per Share of
Common Stock
$
(.10
)
$
.24
Weighted Average Number of Shares
Outstanding For Basic Earnings
894,934
895,994
Weighted Average Number of Shares
Outstanding For Diluted Earnings
894,934
895,994
In view of current considerations, the Board of Directors
determined not to declare a dividend for Fiscal Year 2013.
Statements herein that are not descriptions of historical facts
are forward-looking and subject to risk and uncertainties. Actual
results could differ materially from those currently anticipated
due to a number of factors including risks relating to the ability
to continue to extend current government contracts and obtain new
contracts; the actual cost incurred in performing its contracts;
uncertainties relating to clinical trials; dependence on third
parties; and future capital needs.
BIOQUAL, Inc.Mark G. Lewis, Ph.D., CEO,
301-251-2801www.bioqual.com
Bioqual (PK) (USOTC:BIOQ)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Bioqual (PK) (USOTC:BIOQ)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025
Bioqual Inc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Bioqual, Inc. (PN) News Articles